A scalable, patient-centered approach for ?right sizing? Opioid prescribing study

Ended Indefinite Delivery Contract Awarded Last action

Contract number
75F40118D10209
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$2,314,414.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee

Award details come from SAM.gov/FPDS.

About this IDV

The Trustees of the University of Pennsylvania received a single-award indefinite-delivery contract from the Department of Health and Human Services Food and Drug Administration. The contract has a potential value of $2.3M to support a scalable, patient-centered approach to optimizing opioid prescribing practices through September 2023. No set-aside was used in the award.

The original solicitation sought research and development to advance regulatory science and innovation in line with the FDA's public health mission. The University of Pennsylvania will leverage its expertise in clinical practices and biomedical research to conduct the study outlined in the contract. Areas of focus include developing analytical models and collaborative care approaches to minimize health risks while maintaining effective pain management.

Through applying its experience in fields like epidemiology and health outcomes, the University of Pennsylvania aims to deliver data and insights that modernize prescription guidelines in a manner sensitive to patient needs. The contract represents part of the FDA's broader efforts to address the opioid crisis through improving clinical practices and health technologies subject to its regulatory purview.

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Other Administrative Action P00004 $0
Other Administrative Action P00005 $0
Other Administrative Action P00003 $0
Other Administrative Action P00002 $1,191,962
Exercise an Option P00001 $470,690
Original award $651,762

Quick answers

Who was awarded contract 75F40118D10209?

75F40118D10209 was awarded to The Trustees Of The University Of Pennsylvania by Food and Drug Administration (Department of Health and Human Services) on September 27, 2018.

How much is contract 75F40118D10209 worth?

75F40118D10209's own ceiling is $2,314,414.

Who can order from contract 75F40118D10209?

75F40118D10209 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75F40118D10209 competed?

The extent of competition for 75F40118D10209 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV